These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28934202)

  • 1. Platelet dysfunction contributes to bleeding complications in patients with probable leptospirosis.
    Tunjungputri RN; Gasem MH; van der Does W; Sasongko PH; Isbandrio B; Urbanus RT; de Groot PG; van der Ven A; de Mast Q
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005915. PubMed ID: 28934202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Device-induced platelet dysfunction in mechanically assisted circulation increases the risks of thrombosis and bleeding.
    Chen Z; Zhang J; Kareem K; Tran D; Conway RG; Arias K; Griffith BP; Wu ZJ
    Artif Organs; 2019 Aug; 43(8):745-755. PubMed ID: 30805954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desialylation of platelets induced by Von Willebrand Factor is a novel mechanism of platelet clearance in dengue.
    Riswari SF; Tunjungputri RN; Kullaya V; Garishah FM; Utari GSR; Farhanah N; Overheul GJ; Alisjahbana B; Gasem MH; Urbanus RT; de Groot PG; Lefeber DJ; van Rij RP; van der Ven A; de Mast Q
    PLoS Pathog; 2019 Mar; 15(3):e1007500. PubMed ID: 30849118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the antagonism of von Willebrand factor but not fibrinogen by platelet alphaIIbbeta3 antagonists with prolongation of bleeding time.
    Aoki T; Tomiyama Y; Honda S; Mihara K; Yamanaka T; Okubo M; Moriguchi A; Mutoh S
    J Thromb Haemost; 2005 Oct; 3(10):2307-14. PubMed ID: 16150045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
    Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
    Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. von Willebrand factor mutation promotes thrombocytopathy by inhibiting integrin αIIbβ3.
    Casari C; Berrou E; Lebret M; Adam F; Kauskot A; Bobe R; Desconclois C; Fressinaud E; Christophe OD; Lenting PJ; Rosa JP; Denis CV; Bryckaert M
    J Clin Invest; 2013 Dec; 123(12):5071-81. PubMed ID: 24270421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calpain regulation of cytoskeletal signaling complexes in von Willebrand factor-stimulated platelets. Distinct roles for glycoprotein Ib-V-IX and glycoprotein IIb-IIIa (integrin alphaIIbbeta3) in von Willebrand factor-induced signal transduction.
    Yuan Y; Dopheide SM; Ivanidis C; Salem HH; Jackson SP
    J Biol Chem; 1997 Aug; 272(35):21847-54. PubMed ID: 9268316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of von Willebrand factor binding to activated platelets from healthy neonates and adults.
    Schmugge M; Rand ML; Bang KW; Mody M; Dunn MS; Amankwah KS; Blanchette VS; Freedman J
    Pediatr Res; 2003 Oct; 54(4):474-9. PubMed ID: 12815111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a single bout of strenuous exercise on platelet activation in female ApoE/LDLR
    Przyborowski K; Kassassir H; Wojewoda M; Kmiecik K; Sitek B; Siewiera K; Zakrzewska A; Rudolf AM; Kostogrys R; Watala C; Zoladz JA; Chlopicki S
    Platelets; 2017 Nov; 28(7):657-667. PubMed ID: 28067100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis.
    Brusilovskaya K; Simbrunner B; Lee S; Eichelberger B; Bauer D; Zinober K; Schwabl P; Mandorfer M; Panzer S; Reiberger T; Gremmel T
    Platelets; 2022 Aug; 33(6):879-886. PubMed ID: 35294323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. von Willebrand factor bound to glycoprotein Ib is cleared from the platelet surface after platelet activation by thrombin.
    Hourdillé P; Gralnick HR; Heilmann E; Derlon A; Ferrer AM; Vezon G; Nurden AT
    Blood; 1992 Apr; 79(8):2011-21. PubMed ID: 1562727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linear relationship between ADAMTS13 activity and platelet dynamics even before severe thrombocytopenia.
    Song J; Lee KA; Park TS; Park R; Choi JR
    Ann Clin Lab Sci; 2008; 38(4):368-75. PubMed ID: 18988930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration in GPIIb/IIIa Binding of VWD-Associated von Willebrand Factor Variants with C-Terminal Missense Mutations.
    König G; Obser T; Marggraf O; Schneppenheim S; Budde U; Schneppenheim R; Brehm MA
    Thromb Haemost; 2019 Jul; 119(7):1102-1111. PubMed ID: 31035301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of von Willebrand factor-platelet interaction by fibrinogen.
    Piétu G; Cherel G; Marguerie G; Meyer D
    Nature; 1984 Apr 12-18; 308(5960):648-9. PubMed ID: 6324004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation.
    Grainick HR; Williams SB; Coller BS
    J Clin Invest; 1985 Jan; 75(1):19-25. PubMed ID: 2981249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet physiology and thrombosis.
    Andrews RK; Berndt MC
    Thromb Res; 2004; 114(5-6):447-53. PubMed ID: 15507277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet Activation and Reactivity in a Large Cohort of Patients with Gaucher Disease.
    Revel-Vilk S; Naamad M; Frydman D; Freund MR; Dinur T; Istaiti M; Becker-Cohen M; Falk R; Broide E; Michelson AD; Frelinger AL; Zimran A
    Thromb Haemost; 2022 Jun; 122(6):951-960. PubMed ID: 34507369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of aspirin on platelet-von Willebrand factor surface expression on thrombin and ADP-stimulated platelets.
    Parker RI; Gralnick HR
    Blood; 1989 Nov; 74(6):2016-21. PubMed ID: 2529923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High shear stress attenuates agonist-induced, glycoprotein IIb/IIIa-mediated platelet aggregation when von Willebrand factor binding to glycoprotein Ib/IX is blocked.
    Iijima K; Murata M; Nakamura K; Kitaguchi T; Handa M; Watanabe K; Fujimura Y; Yoshioka A; Ikeda Y
    Biochem Biophys Res Commun; 1997 Apr; 233(3):796-800. PubMed ID: 9168936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of procoagulant potential in patients with reactive thrombocytosis and its association with platelet count.
    Rottenstreich A; Shai E; Kleinstern G; Spectre G; Varon D; Kalish Y
    Eur J Haematol; 2018 Mar; 100(3):286-293. PubMed ID: 29240268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.